Damé Idossa

559 total citations · 1 hit paper
22 papers, 256 citations indexed

About

Damé Idossa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gender Studies. According to data from OpenAlex, Damé Idossa has authored 22 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Gender Studies. Recurrent topics in Damé Idossa's work include HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (4 papers) and Diversity and Career in Medicine (4 papers). Damé Idossa is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (4 papers) and Diversity and Career in Medicine (4 papers). Damé Idossa collaborates with scholars based in United States, India and Türkiye. Damé Idossa's co-authors include Hope S. Rugo, Laura A. Huppert, Özge Gümüşay, Douglas A. Simonetto, Ayalew Tefferi, Terra L. Lasho, Naseema Gangat, Animesh Pardanani, Mrinal M. Patnaik and Christy M. Finke and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and CA A Cancer Journal for Clinicians.

In The Last Decade

Damé Idossa

19 papers receiving 253 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

2023 96 citations Laura A. Huppert, Özge Gümüşay et al. CA A Cancer Journal for Clinicians profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Damé Idossa United States	7	107	77	73	59	53	22	256
Jacqueline Wang United States	9	125 1.2×	46 0.6×	42 0.6×	33 0.6×	37 0.7×	20	279
Nazanin Aghel Canada	11	99 0.9×	51 0.7×	79 1.1×	35 0.6×	29 0.5×	17	286
Annelieke E.C.A.B. Willemsen Netherlands	10	145 1.4×	102 1.3×	33 0.5×	45 0.8×	23 0.4×	25	298
K Govind Babu India	9	124 1.2×	42 0.5×	32 0.4×	33 0.6×	63 1.2×	33	250
Dirk Hempel Germany	8	72 0.7×	61 0.8×	43 0.6×	18 0.3×	29 0.5×	35	186
Sreekanth Reddy United States	6	178 1.7×	96 1.2×	47 0.6×	24 0.4×	28 0.5×	11	289
Nour Moukalled Lebanon	11	192 1.8×	55 0.7×	193 2.6×	61 1.0×	18 0.3×	43	406
Michelle Purdom United States	7	129 1.2×	75 1.0×	29 0.4×	71 1.2×	40 0.8×	13	293
Shanbo Cao China	9	68 0.6×	77 1.0×	40 0.5×	26 0.4×	61 1.2×	46	219

Countries citing papers authored by Damé Idossa

Since Specialization

Citations

This map shows the geographic impact of Damé Idossa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damé Idossa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damé Idossa more than expected).

Fields of papers citing papers by Damé Idossa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damé Idossa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damé Idossa. The network helps show where Damé Idossa may publish in the future.

Co-authorship network of co-authors of Damé Idossa

This figure shows the co-authorship network connecting the top 25 collaborators of Damé Idossa. A scholar is included among the top collaborators of Damé Idossa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damé Idossa. Damé Idossa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsai, Alexander K., Michelle Tregear, Damé Idossa, et al.. (2025). Comparing the time spent in clinic by patients receiving, subcutaneous and intravenous formulations of cancer drugs: A pilot study. Journal of Cancer Policy. 45. 100625–100625.

Dempsey, Naomi, Christine L. Moe, Laura A. Huppert, et al.. (2025). Treatment rechallenge after trastuzumab-deruxtecan–related interstitial lung disease: A multi-institution cohort study.. Journal of Clinical Oncology. 43(16_suppl). 1015–1015. 4 indexed citations

Canchola, Alison J., Meg McKinley, Alice Guan, et al.. (2024). Disparities in Cancer Stage Shifts Associated with the COVID-19 Pandemic in California, 2020 to 2021. Cancer Epidemiology Biomarkers & Prevention. 34(1). 139–150. 1 indexed citations

Huppert, Laura A., Reshma Mahtani, Naomi Dempsey, et al.. (2024). Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC): Updated data and subgroup analyses by age, sites of disease, and use of intervening therapies.. Journal of Clinical Oncology. 42(16_suppl). 1083–1083. 7 indexed citations

Huppert, Laura A., Reshma Mahtani, Naomi Dempsey, et al.. (2024). Abstract PO4-12-06: Interstitial Lung Disease (ILD) in Sequential Antibody Drug Conjugate (ADC) use in patients with Metastatic Breast Cancer (MBC): A Multi-Institutional experience. Cancer Research. 84(9_Supplement). PO4–12. 1 indexed citations

Idossa, Damé, et al.. (2023). Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology Subspecialties. JCO Oncology Practice. 19(10). 899–906. 1 indexed citations

Huppert, Laura A., Özge Gümüşay, Damé Idossa, & Hope S. Rugo. (2023). Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer. CA A Cancer Journal for Clinicians. 73(5). 480–515. 96 indexed citations breakdown →

Idossa, Damé, et al.. (2023). ERBB2-Low (Also Known as HER2-Low) Breast Cancer. JAMA Oncology. 9(4). 576–576. 2 indexed citations

Idossa, Damé, et al.. (2023). Improving clinical trial consent form readability through artificial intelligence.. JCO Oncology Practice. 19(11_suppl). 109–109. 1 indexed citations

10.

Idossa, Damé, Giselle Alexandra Suero‐Abreu, Idalid Franco, et al.. (2023). What is your preferred language? Evaluating equal access to oncology clinical studies for non-English-speaking participants.. Journal of Clinical Oncology. 41(16_suppl). 6547–6547. 2 indexed citations

11.

Idossa, Damé, Hala T. Borno, Mark J. Pletcher, et al.. (2022). Ethnic and Racial Inequities in Cancer Screening During the COVID-19 Pandemic: a multi-site observational study in the United States. 2(2). 3 indexed citations

12.

Idossa, Damé, Terence W. Friedlander, Channing J. Paller, Charles J. Ryan, & Hala T. Borno. (2022). Case Report: Clinical Characteristics and Outcomes of HIV Positive Patients With Metastatic Prostate Cancer Treated With Immunotherapy: A Case Series and Literature Review. Frontiers in Oncology. 12. 910115–910115. 3 indexed citations

13.

Singh, Sunny, Damé Idossa, Fumiko Chino, et al.. (2022). The parent penalty: Parental leave and return to work in trainees and early-career faculty in oncology.. Journal of Clinical Oncology. 40(16_suppl). 11005–11005.

14.

Kim, Luke, et al.. (2022). Quality and content of online cancer information: An analysis of NCI-designated cancer center YouTube videos.. Journal of Clinical Oncology. 40(16_suppl). 11041–11041. 1 indexed citations

15.

Singh, Sunny, Damé Idossa, Fumiko Chino, et al.. (2022). Where is your lactation room? Lactation policies and practices in oncology trainee and early career physicians.. Journal of Clinical Oncology. 40(16_suppl). 11054–11054.

16.

Duma, Narjust, Damé Idossa, Urshila Durani, et al.. (2019). Influence of Sociodemographic Factors on Treatment Decisions in Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 21(3). e115–e129. 18 indexed citations

17.

Idossa, Damé, Terra L. Lasho, Christy M. Finke, et al.. (2018). Mutations and karyotype predict treatment response in myelodysplastic syndromes. American Journal of Hematology. 93(11). 1420–1426. 21 indexed citations

18.

Tefferi, Ayalew, Terra L. Lasho, Mrinal M. Patnaik, et al.. (2017). Targeted next‐generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS‐R. American Journal of Hematology. 92(12). 1311–1317. 56 indexed citations

19.

Idossa, Damé & Douglas A. Simonetto. (2017). Infectious Complications and Malignancies Arising After Liver Transplantation. Anesthesiology Clinics. 35(3). 381–393. 21 indexed citations

20.

Tse, Chung Sang, Nicholas Y. Tan, Damé Idossa, & Roger L. Click. (2017). Cardiac melanoma: Retrospective review of a rare disease at the Mayo clinic (1988–2015). International Journal of Cardiology. 249. 383–386. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact